Diagnosis and Treatment Algorithm for Blood Flow Obstructions in Patients With Left Ventricular Assist Device

Journal of the American College of Cardiology

Volumn 67, Issue 23, 2016, Pages 2758-2768

  Scandroglio, Anna Mara ^a   Kaufmann, Friedrich ^b   Pieri, Marina ^a   Kretzschmar, Alexandra ^b   Müller, Marcus ^b   Pergantis, Panagiotis ^b   Dreysse, Stephan ^b   Falk, Volkmar ^b,c,d   Krabatsch, Thomas ^b,c   Potapov, Evgenij V ^b,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

algorithm; complication; left ventricular assist device; mechanical circulatory support; thrombosis

Indexed keywords

LACTATE DEHYDROGENASE; TIROFIBAN; FIBRINOLYTIC AGENT; TYROSINE;

ADULT; ALGORITHM; ARTICLE; BLOOD CLOT LYSIS; BLOOD FLOW OBSTRUCTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTRA PUMP THROMBOSIS; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT MONITORING; POST PUMP THROMBOSIS; PRE PUMP THROMBOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; THROMBOSIS; TREATMENT ALGORITHM; VASCULAR DISEASE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; DEVICE FAILURE; DEVICES; EQUIPMENT DESIGN; HEART ASSIST DEVICE; MORTALITY; THROMBECTOMY;

ALGORITHMS; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FEMALE; FIBRINOLYTIC AGENTS; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBECTOMY; THROMBOSIS; TYROSINE;

EID: 84978264031     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.03.573     Document Type: Article

References (27)

1. 1 Najjar, S.S., Slaughter, M.S., Pagani, F.D., et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant 33 (2014), 23–34.
2. 2 Aaronson, K.D., Slaighter, M.S., Miller, L.W., et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 125 (2012), 3191–3200.
3. 3 Soltani, S., Kaufmann, F., Vierecke, J., et al. Design changes in continuous-flow left ventricular assist devices and life-threatening pump malfunctions. Eur J Cardiothorac Surg 47 (2015), 984–989.
4. 4 Birati, E.Y., Rame, J.E., Diagnosis and management of LVAD thrombosis. Curr Treat Options Cardiovasc Med, 17, 2015, 361.
5. 5 Stepanenko, A., Krabatsch, T., Hennig, E., et al. Retrospective hemolysis comparison between patients with centrifugal biventricular assist and left ventricular assist devices. ASAIO J 57 (2011), 382–387.
6. 6 Interagency Registry for Mechanically Assisted Circulatory Support, National Heart Lung and Blood Institute. Adverse event definitions. Available at: https://www.uab.edu/medicine/intermacs/appendices-4-0/appendix-a-4-0. Accessed April 12, 2016.
7. 7 Kaufmann, F., Hörmandinger, C., Stepanenko, A., et al. Acoustic spectral analysis for determining pump thrombosis in rotary blood pumps. ASAIO J 60 (2014), 502–507.
8. 8 Bartoli, C.R., Ghotra, A.S., Pachika, A.R., et al. Hematologic markers better predict left ventricular assist device thrombosis than echocardiographic or pump parameters. Thorac Cardiovasc Surg 62 (2014), 414–418.
9. 9 Katz, J.N., Jensen, B.C., Chang, P.P., et al. A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy. J Heart Lung Transplant 34 (2015), 701–709.
10. 10 Baumann Kreuziger, L.M., Kim, B., Wieselthaler, G.M., Antithrombotic therapy for left ventricular assist devices in adults: a systematic review. J Thromb Haemost 13 (2015), 946–955.
11. 11 Heilmann, C., Geisen, U., Benk, C., et al. Haemolysis in patients with ventricular assist devices: major differences between systems. Eur J Cardiothorac Surg 36 (2009), 580–584.
12. 12 Wieselthaler, G.M., O Driscoll, G., Jansz, P., et al. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant 29 (2010), 1218–1225.
13. 13 Jabbar, A.A., Yau, R., Frazier, O.H., Delgado, R. 3rd, Direct thrombolytic therapy for thrombosis of a centrifugal flow left ventricular assist device. ASAIO J 59 (2013), 530–532.
14. 14 Feldman, D., Pamboukian, S., Teuteberg, J.J., et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: Executive Summary. J Heart Lung Transplant 32 (2013), 157–187.
15. 15 Uriel, N., Morrison, K.A., Garan, A.R., et al. Development of a novel echocardiographiy ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices. The Columbia Ramp Study. J Am Coll Cardiol 60 (2012), 1764–1775.
16. 16 Potapov, E., Krabatsch, T., Buz, S., Falk, V., Kempfert, J., Cerebral protection system applied during washout of thrombus occluding inflow cannula of HeartWare HVAD left ventricular assist devices. J Heart Lung Transplant 34 (2015), 1640–1641.
17. 17 Potapov, E.V., Krabatsch, T., Hübler, M., Hetzer, R., Subcostal approach for replacement of failing circulatory pumps. J Thorac Cardiovasc Surg, 144, 2012, 1272.
18. 18 Potapov, E., Stepanenko, A., Kaufmann, F., et al. Thrombosis and cable damage in the HeartWare Pump: clinical decisions and surgical technique. ASAIO J 59 (2013), 37–40.
19. 19 Abraham, J., Remick, J.D., Caulfield, T., et al. Left ventricular assist device outflow cannula obstruction treated with percutaneous endovascular stenting. Circ Heart Fail 8 (2015), 229–230.
20. 20 Pham, D.T., Kapur, N.K., Dermody, M., Halin, N., Stenting of an outflow graft obstruction after implantation of a continuous-flow, axial-flow left ventricular assist device. J Thorac Cardiovasc Surg 150 (2015), e11–e12.
21. 21 Cheng, R.K., Aboulhosn, J., Nsair, A., Percutaneous angioplasty of stenotic outflow graft anastomosis of HeartMate II. J Am Coll Cardiol Intv 7 (2014), 700–703.
22. 22 Pieri, M., Scandroglio, A.M., Kukucka, M., et al. Heart failure after five years on left ventricular assist device: diagnosis and treatment of out-flow graft obstruction. ASAIO J, 2016 [e-pub ahead of print].
23. 23 Naber, C.K., Ghanem, A., Abizaid, A.A., et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention 8 (2012), 43–50.
24. 24 Lansky, A.J., Schofer, J., Tchetche, D., et al. A prospective randomized evaluation of the TriGuard HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J 36 (2015), 2070–2078.
25. 25 Stulak, J.M., Dunlay, S.M., Sharma, S., et al. Treatment of device thrombus on the HeartWare HVAD: success and outcomes depend significantly on the initial treatment strategy. J Heart Lung Transplant 34 (2015), 1535–1541.
26. 26 Jorde, U.P., Aaronson, K.D., Najjar, S.S., et al. Identification and management of pump thrombus in the HeartWare left ventricular assist device system. J Am Coll Cardiol HF 3 (2015), 849–856.
27. 27 Stewart, G.C., Givertz, M.M., Mehra, M.R., Pump thrombosis redux. J Heart Lung Transplant 34 (2015), 1511–1514.